Free Trial

MiNK Therapeutics (INKT) SEC Filings & 10K Form

MiNK Therapeutics logo
$7.10 0.00 (-0.06%)
Closing price 05/23/2025 03:58 PM Eastern
Extended Trading
$7.86 +0.77 (+10.84%)
As of 05/23/2025 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MiNK Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:03 PM
MiNK Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:52 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:17 PM
MiNK Therapeutics (Filer)
Form DEF 14A
12/06/2024
4:09 PM
MiNK Therapeutics (Filer)
Form PRE 14A
12/03/2024
9:35 AM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:38 AM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:44 AM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:44 AM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:15 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:18 AM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:22 AM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:23 AM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:23 AM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2024
11:15 PM
MiNK Therapeutics (Filer)
Form EFFECT
08/16/2024
3:39 PM
MiNK Therapeutics (Filer)
Form 424B3
08/13/2024
3:34 PM
MiNK Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/13/2024
3:18 PM
MiNK Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/13/2024
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
1:22 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
1:24 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
1:27 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
1:27 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INKT) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners